Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanosys Signs Two Cooperation Agreements With Harvard University to Combine Intellectual Property Assets Covering Fundamental Nanowire Technology to Address Non-Volatile Memory and

Abstract:
The Combined IP Portfolio Offers Attractive Opportunity for Companies Seeking to License Leading Nanowire Technologies

Nanosys Signs Two Cooperation Agreements With Harvard University to Combine Intellectual Property Assets Covering Fundamental Nanowire Technology to Address Non-Volatile Memory and

Palo Alto, CA | Posted on April 24th, 2009

Nanosys Inc. today announced that it has signed two agreements with Harvard University to combine their extensive intellectual property (IP) assets to facilitate out-licensing in two areas: nanowire-based biosensors and nanowire-based non-volatile memories. The IP is available for out-licensing to any interested third parties. The technologies being made available originate from the laboratory of Dr. Charles Lieber (Mark Hymen Professor of Chemistry at Harvard University), as well as many other nanotech researchers at Nanosys and other universities associated with Nanosys. The IP on offer includes Nanosys' extensive portfolio covering all aspects of nanowire production, functionalization, material interface technologies, fabrication technologies, basic devices using nanostructures, applications and architectures, and Harvard's portfolio of nanowire-based biosensor and non-volatile memory related IP.

"The agreements between Nanosys and Harvard reflect an innovative strategy to facilitate the development of two novel disruptive technologies," said Isaac T. Kohlberg, Harvard University's Senior Associate Provost and Chief Technology Development Officer. "We're delighted to be working in concert with Nanosys, a recognized leader in the nanowire space, to identify companies interested in acquiring rights to our innovative nanowire technologies for next-generation biosensors and non-volatile memory."

Andrew Filler, General Counsel and Vice-President of Intellectual Property at Nanosys, commented: "As companies are now realizing the significant commercial value of nanotechnology to expand upon and open up new markets, our goal is to help these companies address these markets using our intellectual property portfolio." He added, "After developing many fundamental technology platforms at Nanosys over the last several years, the company is now focused on commercializing technologies in core business areas including solid state lighting, electronics, energy storage and medical device applications. Our nanotechnology licensing program complements our core business focus, thereby providing the market with a convenient licensing option to our fundamental patent portfolio in areas that we are not fully exploiting ourselves."

####

About Nanosys Inc.
Nanosys, Inc. is a leader in the development of nanotechnology-enabled products utilizing high performance inorganic nanostructures. Nanosys has built one of the broadest technology platforms in the industry with over 650 patents and patent applications covering fundamental areas of nanotechnology. Based in Palo Alto, California and privately held, Nanosys collaborates with industry leaders to develop revolutionary high-value, high-performance products for life sciences, computing, optoelectronics, renewable energy, and defense.

For more information, please click here

Contacts:
Nanosys Contact:
Andrew Filler
General Counsel and Vice President of Intellectual Property
Tel. 650 331-2176

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024

Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Chip Technology

New material to make next generation of electronics faster and more efficient With the increase of new technology and artificial intelligence, the demand for efficient and powerful semiconductors continues to grow November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

New discovery aims to improve the design of microelectronic devices September 13th, 2024

Groundbreaking precision in single-molecule optoelectronics August 16th, 2024

Nanoelectronics

Interdisciplinary: Rice team tackles the future of semiconductors Multiferroics could be the key to ultralow-energy computing October 6th, 2023

Key element for a scalable quantum computer: Physicists from Forschungszentrum Jülich and RWTH Aachen University demonstrate electron transport on a quantum chip September 23rd, 2022

Reduced power consumption in semiconductor devices September 23rd, 2022

Atomic level deposition to extend Moore’s law and beyond July 15th, 2022

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project